Biovie (BIVI) Net Equity Issued and Repurchased (2016 - 2025)
Biovie's Net Equity Issued and Repurchased came in at $10.46 million for FY2026 (year ended Jun 30, 2026), down 33.3% from $15.67 million in FY2025.
Powered by 
Analysis
Biovie (BIVI) Net Equity Issued and Repurchased (2016 - 2025) Analysis & Trends
Going back to FY2013, Biovie's Net Equity Issued and Repurchased data covers 10 fiscal years.
- Net Equity Issued and Repurchased has declined in each of the last three fiscal years, with a five-year compound annual growth rate of -7.7% (FY2021 to FY2026).
- The FY2026 figure represents the lowest annual Net Equity Issued and Repurchased since FY2018.
- Per Business Quant, earlier fiscal years put Net Equity Issued and Repurchased at $15.67 million in FY2025 (-43.6%), $27.8 million in FY2024 (-43.8%), $49.47 million in FY2023 (+167.2%) and $18.51 million in FY2022 (+18.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Biovie | 11.09 Mn | 11.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 10.46 Mn |
| Dec 31, 2024 | 13.42 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 18.48 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 9.77 Mn |
| Dec 31, 2022 | 32.52 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Sep 30, 2021 | 18.51 Mn |
| Mar 31, 2021 | 516,551.00 |
| Sep 30, 2020 | 15.63 Mn |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2018 | 1,998.00 |
| Mar 31, 2018 | 50,001.00 |
| Dec 31, 2017 | 149,999.00 |
| Sep 30, 2017 | 245,001.00 |
| Jun 30, 2017 | 70,000.00 |
| Mar 31, 2017 | 310,012.00 |
API Access
Biovie Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();